Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Edoxudine Market

Edoxudine Market by Formulation Type (Cream and Ointment), Application (Herpes Simplex Virus) and Distribution Channel (Hospitals and Drug Stores): Global Opportunity Analysis and Industry Forecast, 2021-2030

A12477
Pages: NA
Sep 2021 | 140 Views
   
Author(s) : Onkar Sumant
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Edoxudine Market

Request Now !

Edoxudine Market Overview 2030

Edoxudine (Edoxudin), an antiviral drug, is a deoxythymidine analog with activity against herpes simplex virus. It is a potent and selective inhibitor of herpes simplex virus type 1 and 2. The obtained product is an antiviral ointment. The activity of edoxudine against herpes simplex virus was first recognized in 1967. It was later recognized to be effective in vivo in a preclinical model of keratitis caused by herpes virus. It was developed by McNeil Pharmaceutical and approved by Health Canada on December 31, 1992.

Edoxudine was used in Europe, in the form of a topical antiviral, for the treatment of human herpes keratitis. Human herpes keratitis is an inflammation of the cornea in the eye caused by herpes simplex virus infection. This infection is a cause of significant morbidity whose incidence is significantly increased in the presence of recurrent infection and it can even produce corneal blindness.

Market Scope Structure Analysis

Report Metric

Details

 Market Size Available for Years

 2020-2030

 Base Year Considered

 2020

 Forecast Period

 2021-2030

 Forecast Unit

 USD

 Segments Covered

 Formulation Type, Application, Distribution  Channel, and Region

 Regions Covered

 North America, Europe, Asia-Pacific, LAMEA

 Companies Covered

Bausch Health Companies Inc., Cipla Inc., Eli Lilly and Co., Gilead Sciences Inc., GlaxoSmithKline Plc

Maruho Co. Ltd., Merck & Co. Inc., Mylan NV, Novartis AG, Teva Pharmaceutical Industries Ltd.

 

 

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the edoxudine market.
  • The sudden outbreak of the COVID-19 pandemic has made an optimistic effect on the global edoxudine market growth. The strong growth of the market due to the COVID-19 is mainly attributed to the increasing focus of the major market players for the treatment development of COVID-19 drugs. For instance, in May 2020, in the virtual screening of the molecules with NSP1, the team described FDA-approved anti-viral drugs such as Remdesivir and Edoxudine as promising as Covid-19 treatment at National Center for Biological Sciences (NCBS), Bengaluru. The R&D activities on the potential lead molecules are expected to boost the market and are expected to do so even in the forecast period.
  • The structural reposition and development of the drug for screening and repurposing in COVID-19 is anticipated to bring a significant rise in the market during the forecast period.

Top Impacting Factors

  • Rise in prevalence of HSV infection, increase in rate of new infections, and continuous mutations in the microorganisms leading to new strains are key factors that are driving the global herpes simplex virus infection treatment market. Increase in transmission of infectious diseases and lack of cleanliness in developing regions further fuel the growth of the edoxudine market.
  • Edoxudine is been reported to present cytotoxic effects, some degree of DNA incorporation in human leukemic cells, PHA-stimulated lymphocytes in vitro, and other severe side effects that caused its discontinuation from the market, hence, acting as a restraint in its market growth.
  • Rise in burden of HSV encephalitis is anticipated to propel the market in this particular segment. As per the National Organizations for Rare Disorders, the prevalence of acute encephalitis in the U.S. is around 2,000 cases per year, and it includes around 10% of total cases of encephalitis occurring in the U.S.

Market Trends

The global edoxudine market was valued at XXUSD in 2020 and will reach XX USD million by the end of 2028, growing at a CAGR of XX% during 2020-2028. 

More than 80% herpes infections are asymptomatic, because of which physicians depend on diagnostic tests for correct diagnosis and treatment. Edoxudine is very effective against herpes infection as it directly targets DNA of viral material. The development in modification of edoxudine can boost its market growth.

Coronavirus infection segment is expected to observe XX% growth rate till 2028. Increase in R&D activities pertaining to coronavirus infection is anticipated to drive the industry revenue. Edoxudine is another clinically proven promising treatment against the infection and tested among few patients. With rise in demand for anti-viral drug therapy for coronavirus infection, the segment is expected to grow at a significant rate over the forecast period.

Using computational biology techniques, the three-member team at NCBS, which is a biological center of the Tata Institute of Fundamental Research, found that only one in 10,000 screened molecules has the potential to target the protein. In the virtual screening of the molecules with NSP1, the team described FDA-approved anti-viral drugs such as remdesivir and edoxudine as “promising” for COVID-19 treatment.

After the discontinuation of drug from the market the industries have suffered heavy losses, but now technology has made possible to dock the drug in various diseases and its chemical modification can repurpose the drug back in the market. The repurposing of drugs in novel therapies make it ideal for investors to take the interest in the market which boosts the market. The screening of edoxudine for COVID-19 treatment makes opportunity for growth of the edoxudine market during the forecast period.

Key Segments Covered

Segment

Sub-Segment

 By Formulation Type

  • Cream
  • Ointment

 Application

  • Herpes Simplex Virus
    • Genital Herpes Infection
    • Human Herpes Keratitis

 Distribution Channel

  • Hospitals
  • Drug Stores/ Pharmacies

 Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

 

Key Benefits of Report

  • This report presents the detailed analytical depiction of the edoxudine market along with current trends, opportunities, and future estimates for the investment in market.
  • The report presents information related to the key drivers, restraints, and opportunities in the edoxudine market.
  • The current market is analyzed from 2020 to 2028 to emphasize the edoxudine market.
  • Porter’s five forces analysis illustrate the potency of buyers and suppliers in market.
  • The report provides detailed analysis of the edoxudine market based on market competition and how it is expected to take shape in the future.

Questions Answered in the Biotechnology Services Market Report

  • What is the mechanism of action of edoxudine?
  • What are edoxudine products used for?
  • What are current trends that will influence the market in upcoming years?
  • What are the driving factors, restraints, and opportunities of the market?
  • Which are the leading players in the edoxudine market?
  • What future projections will help in taking future strategic steps?
  •  What are the distribution channels of edoxudine market?
  • What is the major regional market in edoxudine market?
  • What are the key benefits of this edoxudine market report?
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Edoxudine Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers